Clinical Trial Update: NUVOLA TRIAL Open-label Multicentre Study [Phase 2]

View source ↗

Summary

A Phase 2 open-label multicentre trial called NUVOLA in high-grade serous ovarian cancer is described, with Phase 2 status and unknown ongoing status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Serous Ovarian Cancer

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: High Grade Serous Ovarian Cancer | Phase 2 | Status: UNKNOWN